tiprankstipranks
PAVmed Inc (PAVM)
NASDAQ:PAVM

PAVmed (PAVM) Income Statement

434 Followers

PAVmed Income Statement

Last quarter (Q3 2023), PAVmed's total revenue was $791.00K, an increase of 940.79% from the same quarter last year. In Q3, PAVmed's net income was $-17.75M. See PAVmed’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 1.51M$ 377.00K$ 500.00K$ 0.00$ 0.00$ 0.00
Cost of Revenue
$ -1.91M$ 1.65M$ 585.00K$ 0.00--
Gross Profit
$ 699.00K$ 377.00K$ -85.00K$ 0.00--
Operating Expense
$ 118.69M$ 87.69M$ 54.31M$ 23.35M$ 14.29M$ 10.56M
Operating Income
$ -33.71M$ -90.93M$ -54.39M$ -23.35M$ -14.29M$ -10.56M
Net Non Operating Interest Income Expense
$ -794.00K$ -1.27M-$ -713.00K$ -583.00K$ -3.01M
Other Income Expense
$ 10.73M$ 11.04M$ 1.73M$ -11.82M$ -2.39M$ -4.60M
Pretax Income
$ -86.43M$ -103.24M$ -56.13M$ -35.89M$ -17.27M$ -18.17M
Tax Provision
$ -11.12M$ -24.27M$ 18.94M$ 0.00$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -29.20M$ -89.26M$ -50.63M$ -34.56M$ -16.73M$ -18.75M
Basic EPS
$ -0.70$ -1.00$ -0.65$ -0.73$ -0.55$ -0.84
Diluted EPS
$ -0.48$ -1.00$ -0.65$ -0.73$ -0.55$ -0.84
Basic Average Shares
$ 402.46M$ 89.08M$ 77.52M$ 47.43M$ 30.20M$ 22.28M
Diluted Average Shares
$ 313.39M$ 89.08M$ 77.52M$ 47.43M$ 30.20M$ 22.28M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 116.78M$ 89.34M$ 54.89M$ 23.35M$ 14.29M$ 10.56M
Net Income From Continuing And Discontinued Operation
$ -74.88M$ -88.98M$ -50.35M$ -34.28M$ -16.46M$ -17.97M
Normalized Income
$ -27.85M$ -127.09M-$ -22.45M$ -14.07M$ -14.27M
Interest Expense
---$ 53.00K$ 33.00K$ 2.39M
EBIT
$ -85.63M$ -101.97M$ -56.13M$ -35.84M$ -17.23M$ -15.78M
EBITDA
$ -82.15M$ -99.51M$ -55.90M$ -35.81M$ -17.22M$ -15.77M
Currency in USD

PAVmed Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis